Log in to save to my catalogue

Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity

Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6ef1b8477dc94cb884e5bb6309eb3423

Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity

About this item

Full title

Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-11, Vol.13 (1), p.6828-6828, Article 6828

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Cancer-associated fibroblasts (CAFs) mediate an immunosuppressive effect, but the underlying mechanism remains incompletely defined. Here we show that increasing prostatic stromal
Foxf2
suppresses the growth and progression of both syngeneic and autochthonous mouse prostate cancer models in an immunocompetent context. Mechanistically, Foxf2 m...

Alternative Titles

Full title

Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6ef1b8477dc94cb884e5bb6309eb3423

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6ef1b8477dc94cb884e5bb6309eb3423

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-34665-z

How to access this item